-
AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111.
We isolated cDNA clones containing the entire coding region of the putative oncogene AKT2. Sequence analysis and in vitro translation demonstrated that AKT2 encodes a 56-kDa protein with homology to serine/threonine kinases; moreover, this protein contains a Src homology 2-like domain. AKT2 was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. AKT2 was mapped to chromosome region 19q13.1-q13.2 by fluorescence in situ hybridization. In the two ovarian carcinoma cell lines exhibiting amplification of AKT2, the amplified sequences were localized within homogeneously staining regions. We conclude that AKT2 belongs to a distinct subfamily of protein-serine/threonine kinases containing Src homology 2-like domains and that alterations of AKT2 may contribute to the pathogenesis of ovarian carcinomas.
PMID: 1409633 [PubMed - indexed for MEDLINE]
PMCID: PMC50107
-
Cited by 52 PubMed Central articles
-
Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases/Akt signaling pathways.
Xu YH, Zhao LJ, Li Y.
World J Gastroenterol. 2009 Jun 21; 15(23):2870-7.
[World J Gastroenterol. 2009]
-
The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications.
Arcaro A, Guerreiro AS.
Curr Genomics. 2007 Aug; 8(5):271-306.
[Curr Genomics. 2007]
-
Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival.
Sawai H, Yasuda A, Ochi N, Ma J, Matsuo Y, Wakasugi T, Takahashi H, Funahashi H, Sato M, Takeyama H.
BMC Gastroenterol. 2008 Nov 26; 8:56. Epub 2008 Nov 26.
[BMC Gastroenterol. 2008]
- » See all...